ADHD Medication and Substance-Related Problems.

ABSTRACT:

Objective

Substance use disorders are major contributors to excess mortality among individuals with attention deficit hyperactivity disorder (ADHD), yet associations between pharmacological ADHD treatment and substance-related problems remain unclear. This study investigated concurrent and long-term associations between ADHD medication treatment and substance-related events.

Method

The authors analyzed 2005-2014 commercial health care claims from 2,993,887 (47.2% female) adolescent and adult ADHD patients. Within-individual analyses compared the risk of substance-related events (i.e., emergency department visits related to substance use disorders) during months in which patients received prescribed stimulant medication or atomoxetine relative to the risk during months in whi

SUBMITTER: Quinn PD 

PROVIDER: S-EPMC5581231 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature